Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis and evaluation of inhibitors of the SARS-CoV-2 nsp3 macrodomain
Lavinia M. Sherrill, Elva E. Joya, AnnMarie Walker, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 67, pp. 116788-116788
Open Access | Times Cited: 19

Showing 19 citing articles:

Accelerating antiviral drug discovery: lessons from COVID-19
Annette von Delft, Matthew D. Hall, Ann D. Kwong, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 7, pp. 585-603
Open Access | Times Cited: 90
Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2
Stefan Gahbauer, G.J. Correy, M. Schuller, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 2
Open Access | Times Cited: 87
SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice
Yousef M. Alhammad, Srivatsan Parthasarathy, Roshan Ghimire, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 35
Open Access | Times Cited: 37
Discovery of 2-Amide-3-methylester Thiophenes that Target SARS-CoV-2 Mac1 and Repress Coronavirus Replication, Validating Mac1 as an Antiviral Target
Sarah Wazir, Tomi A. O. Parviainen, Jessica J. Pfannenstiel, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6519-6536
Closed Access | Times Cited: 9
A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo
Taha Y. Taha, Rahul K. Suryawanshi, Irene P. Chen, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 8, pp. e1011614-e1011614
Open Access | Times Cited: 17
Derivatives of MOPS: promising scaffolds for SARS coronaviruses Macro domain‐targeted inhibition
Oney Ortega Granda, Karine Alvarez, Benjamin Morin, et al.
FEBS Journal (2025)
Open Access
Extensive exploration of structure activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment merging and active learning
G.J. Correy, Moira Rachman, Takaya Togo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Targeting SARS-CoV-2 nonstructural protein 3: Function, structure, inhibition, and perspective in drug discovery
Xin Li, Yongcheng Song
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103832-103832
Open Access | Times Cited: 11
SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in mice
Yousef M. Alhammad, Srivatsan Parthasarathy, Roshan Ghimire, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Structural and functional analyses of SARS-CoV-2 Nsp3 and its specific interactions with the 5’ UTR of the viral genome
Sofia Lemak, T. Skarina, Robert Flick, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors
Joseph J. O’Connor, Dana Ferraris, Anthony R. Fehr
Pathogens (2023) Vol. 12, Iss. 10, pp. 1221-1221
Open Access | Times Cited: 7
The DarT/DarG Toxin–Antitoxin ADP-Ribosylation System as a Novel Target for a Rational Design of Innovative Antimicrobial Strategies
Giuliana Catara, Rocco Caggiano, Luca Palazzo
Pathogens (2023) Vol. 12, Iss. 2, pp. 240-240
Open Access | Times Cited: 6
Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulation for the Discovery of Novel SARS-CoV-2 NSP3 Mac1 Domain Inhibitors
Behnaz Yazdani, Hajar Sirous, Simone Brogi, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2291-2291
Open Access | Times Cited: 6
GS-441524-Diphosphate-Ribose Derivatives as Nanomolar Binders and Fluorescence Polarization Tracers for SARS-CoV-2 and Other Viral Macrodomains
Kewen Peng, Shamar D. Wallace, Saket R. Bagde, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 5, pp. 1093-1105
Open Access | Times Cited: 1
Discovery of 2-amide-3-methylester thiophenes that target SARS-CoV-2 Mac1 and repress coronavirus replication, validating Mac1 as an anti-viral target
Sarah Wazir, Tomi A. O. Parviainen, Jessica J. Pfannenstiel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 Macrodomain of SARS-CoV-2
Stefan Gahbauer, G.J. Correy, M. Schuller, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
HTRF-based assay for detection of mono-ADP-ribosyl hydrolyzing macrodomains and inhibitor screening
Niklas Ildefeld, Dieter Steinhilber, Ewgenij Proschak, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110333-110333
Open Access
Synthesis of Structural ADP-Ribose Analogues as Inhibitors for SARS-CoV-2 Macrodomain 1
Koen J. Rijpkema, M. Schuller, Miriam S. van der Veer, et al.
Organic Letters (2024) Vol. 26, Iss. 27, pp. 5700-5704
Open Access
The quest to identify ADP-ribosylation readers: methodological advances
S. Weijers, Michiel Vermeulen, Katarzyna W. Kliza
Trends in Biochemical Sciences (2024) Vol. 49, Iss. 11, pp. 1000-1013
Closed Access
Identification of a series of pyrrolo-pyrimidine based SARS-CoV-2 Mac1 inhibitors that repress coronavirus replication
Jessica J. Pfannenstiel, Men Thi Hoai Duong, Daniel Cluff, et al.
(2024)
Open Access
Page 1

Scroll to top